rs1042571 — POMC

The Appetite Brake: How a POMC 3'UTR Variant Weakens Satiety Signaling

Deep in the hypothalamus, a molecular brake system governs whether you feel full after eating. At its center is proopiomelanocortin (POMC), a precursor protein¹¹ precursor protein
A large polypeptide that is cleaved into multiple active hormone fragments by specialized enzymes with an outsized role in body weight regulation. When POMC neurons in the arcuate nucleus are activated by leptin, the resulting peptide cascade — particularly alpha-melanocyte stimulating hormone (alpha-MSH)²² alpha-melanocyte stimulating hormone (alpha-MSH)
A 13-amino-acid neuropeptide that binds MC4R receptors to powerfully suppress appetite and increase energy expenditure — signals the brain to stop eating, reduce appetite, and increase metabolic rate. The rs1042571 variant in the 3' untranslated region (3'UTR) of the POMC gene subtly but consistently alters this signaling system, with measurable consequences for body fat distribution, BMI, and satiety-related eating behaviors.

The Mechanism: mRNA Regulation via miRNA Binding

The rs1042571 variant (reported as C8246T in older literature; on the plus strand, it is a G>A change at chr2:25161018) sits in the 3'UTR of the POMC mRNA — the untranslated tail region that governs mRNA stability, translation efficiency, and post-transcriptional regulation. This region is a critical control point: it contains binding sites for microRNAs³³ microRNAs
Small non-coding RNA molecules that bind to the 3'UTR of target mRNAs to suppress their expression that fine-tune POMC expression.

The A (risk) allele is predicted to lie within the binding sites of two distinct miRNAs⁴⁴ predicted to lie within the binding sites of two distinct miRNAs, disrupting the complementarity between the miRNA seed sequences and the POMC 3'UTR. By altering these miRNA binding sites, the A allele changes the minimum free energy of RNA secondary structure, potentially reducing miRNA-mediated repression. The net functional effect appears to be dysregulated POMC expression — but not in the direction of simple loss of function. Rather, the altered 3'UTR may change the tissue-specific, timing-specific, and stimulus-responsive regulation of POMC transcripts, resulting in a satiety signal that is less precisely tuned to metabolic demands.

The Evidence: Consistent BMI and Body Composition Associations

Several independent studies, using complementary designs, support rs1042571 as a modifier of body composition:

Zhou et al. 2012⁵⁵ Zhou et al. 2012
Identification of POMC Exonic Variants Associated with Substance Dependence and Body Mass Index. PLoS One, 2012 sequenced POMC exons in 308 European Americans and 280 African Americans and identified rs1042571 as a common polymorphism with population-stratified effects. In European Americans, each copy of the T/A (risk) allele doubled the odds of overweight or obese status compared to normal weight (OR 2.0 for overweight+obese vs normal, P_adj = 0.002). This effect was not observed in African Americans, suggesting gene-by-ancestry interactions or LD differences. The authors specifically noted the variant's location in predicted miRNA binding sites as a plausible functional mechanism.

Challis et al. 2005⁶⁶ Challis et al. 2005
Association Between Common Polymorphisms of the POMC Gene and Body Fat Distribution: A Family Study. Diabetes, 2005 examined 1,428 members of 248 families using family-based association testing — a design that controls for population stratification. The C8246T (rs1042571) T allele was significantly associated with a 0.2-standard deviation higher waist-to-hip ratio in a codominant fashion (P < 0.0001), even after correcting for age, sex, BMI, smoking, exercise, and alcohol. Notably, no association was found with total BMI or plasma leptin, suggesting this variant specifically affects the pattern of fat deposition rather than total adiposity.

Hager et al. 2005⁷⁷ Hager et al. 2005
POMC Gene Variants Are Associated with Serum Leptin and Body Fat in a Normal Female Population. European Journal of Human Genetics, 2005 studied 2,758 Caucasian twin women. The 8246 T allele (frequency 0.18) was significantly associated with higher mean BMI (P = 0.032) and total fat percentage (P = 0.046) under a recessive model. Sibling-based transmission disequilibrium testing confirmed associations with waist circumference (P = 0.049), total fat (P = 0.037), and serum leptin levels (P = 0.016).

These converging lines of evidence establish moderate confidence in the association. The effect sizes are modest — approximately 0.2 SD per allele on WHR, and approximately 2-fold increased obesity odds in heterozygotes in European ancestry studies — consistent with POMC rs1042571 functioning as one of many common variants that collectively contribute to polygenic obesity risk.

Practical Implications

Carriers of the A allele, particularly heterozygous AG individuals (approximately 28% of people of European descent) and rarer homozygous AA individuals (~3%), show a tendency toward altered body fat distribution, particularly increased abdominal adiposity as measured by waist-to-hip ratio. The melanocortin pathway that rs1042571 influences is specifically responsive to dietary protein: high-protein meals potently stimulate POMC neurons and alpha-MSH release, which activates MC4R to suppress appetite. For carriers with subtly dysregulated POMC signaling, optimizing protein intake is the most mechanistically targeted dietary intervention.

Waist-to-hip ratio, the phenotype most strongly linked to this variant, is particularly sensitive to dietary pattern and meal timing. The abdominal fat compartment that drives WHR elevations is also the metabolically active depot most associated with insulin resistance and cardiovascular risk — providing additional motivation for targeted management.

Interactions

rs1042571 participates in the broader melanocortin appetite regulation pathway, where multiple genetic variants interact to determine aggregate signaling output. The MC4R variant rs17782313 (MC4R) and the AGRP variant rs3412352 operate in the same appetite-control circuit as POMC: AGRP is the endogenous antagonist of MC4R, while POMC-derived alpha-MSH is its agonist. A three-way interaction analysis using multifactor dimensionality reduction (MDR) in a North Indian cohort found that POMC rs1042571 + MC4R rs17782313 + APOE rs429358 together constituted the best predictor of obesity risk, suggesting these variants act synergistically. Carriers of risk alleles across multiple melanocortin pathway genes may have compound appetite dysregulation exceeding the additive sum of individual variant effects.

The leptin receptor variant rs1137101 (LEPR) is also functionally upstream of POMC: leptin receptor signaling activates POMC neurons to produce alpha-MSH. Impaired leptin signaling combined with POMC 3'UTR dysregulation could compound satiety signaling deficits.